again. once And Marc. you, Thank everybody hello
have transition. a of Recli have smooth the and Kate commercial Marc, and operations for and these enable few to commercial our with And with team changing Joe times. of Federico provide Over directly in strong direction I a weeks, believe I will Seghi the been structure Mike, we the that leadership help multimedia, past working established
the the caused fact previous the by some that our primarily were pandemic. despite COVID-XX sales the action higher quarter, due The revenue than for product quarter plans nominally was first of disruption to the interrupted,
has highlighted, new Marc business. As the outside COVID-XX box, think conducting create of to us made ways
our interactions health in in ways to that process, so in implementing with conduct to them Our this new of virtual to business environment. while has place, putting providers plans assist changes certified staff are creating also we the they a can been continue care rapidly learn
Early this year, we schedule effect supply pricing that announced a into a term. went agreement five-year federal for
made some We with Support Medical organization. have initial the VA inroads
been we However, due unable the necessary have to additional follow-up. restricted conduct to travel,
of travel-related of opioid with in to clinics, the disorder of easing on in use treatment the coming days, interact once we alternative again use expected promote to patients. VA the the ways With also VA seeking key focus will restrictions while Probuphine the
elaborate of Let and we during activities months, me the the on progress some commercial few these making. are past
team such year now professional late a year and As we continued that and sales of with so that addition Rico. have experienced of and States this know, our do sales started Puerto in to we territories you leadership commercial managers, pharmaceutical the XX United our last expanding each sales covers
These sales equally qualified our experienced liaisons supported professionals four within science and medical medical being by are affairs team.
to sales is improve adoption growth. goal Our and generate product
that Probuphine addressing best OUD who of treatment who about who we Key learned criteria and existing providers treatment. of we use assist proper positively much patients believe care support, maintenance long-term results for impact past their the the programs suited have When few those provide Probuphine. include challenges, the treatment health for meet the factors target can those the in we months’ selection of identifying
have plans now experience, this those manage procedure. insertion educational are they we for with We experienced authorization, coverage And ease. in so clinics can the third-party with managing selecting to don’t that prior staff due payer providing require that staff are relative adequate process the subdermal support,
We’re being proactive.
focusing adequate, nurse procedure get while the and health third-party we We’re as being to appropriately providers this on for the providers, physician care attractive who health pursue practitioners ways assistants, also consider payers reimbursement more -- care attracting reimburse current including to activity.
to providers care patients health caregivers stability step acting easily and for of that to benefits educate and information pamphlets into Probuphine created campaign. the have medication long provide the a like about promote important We
our time provide communication as staff, establish benefits to techniques potential telemedicine care and in new have the resources increasing using this working from their with health to communication use with virtual home, to Probuphine modality this providers relationships these work for treatment digital care providers we and our highlight of During preparatory limited shifted and focus tools a environment. of patients their health
We increase it. very treatment assisted of presence to have and geographies our enhance we awareness to in medication working share of a plan select media also has established social Probuphine expand well, and been in the space. voice This
the to relaxed. is Probuphine the with relationships the Probuphine, and once establish inform of of usage increase in patients goal order with restrictions medical medical community to mobility the are long-acting strong on option treatment Our businesses and
important option. an capital We resources, and with strongly care the battle their providing disorder, has weapon opioid the patients potential be sufficient use against with health important an Probuphine in believe maintenance treatment providers, caregivers to that
implement we model, have continuing have of to a We our These support number option prefer to increase prescribe physicians active to by model the could insert model indications hope to who REMS those this supporting on are only clinicians, a prescribers the which patient expand Probuphine. and wherever aims clinician initial their certified for success, clinicians. patients to potential both this remove Probuphine of remove appropriate. which behalf, barrier and With
drug Titan’s as Chief let A safety medical DeVarney, activity. me progress compliance our product development regulatory said, Dr. lot that our as discuss Officer, well over to will turn our Scientific call Kate? the Kate With handle. affairs, things functions, now and who to on of and
